MEDPLUS.NS(MEDPLUS.NS)
MEDPLUS.NS
No analyst ratings available
No analyst price targets available for MEDPLUS.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $78.46B | $89.72B | $102.29B | $117.00B |
| Low | $75.41B | $83.32B | $100.47B | $110.42B |
| High | $80.36B | $94.71B | $104.11B | $121.81B |
| EBITDA Avg | $12.14B | $13.88B | $15.82B | $18.10B |
| Low | $11.66B | $12.89B | $15.54B | $17.08B |
| High | $12.43B | $14.65B | $16.10B | $18.84B |
| EBIT Avg | $6.35B | $7.26B | $8.28B | $9.47B |
| Low | $6.11B | $6.75B | $8.14B | $8.94B |
| High | $6.51B | $7.67B | $8.43B | $9.86B |
| Net Income Avg | $2.59B | $3.27B | $5.75B | — |
| Low | $2.42B | $2.42B | $5.38B | — |
| High | $2.84B | $4.61B | $6.12B | — |
| EPS Avg | $21.84 | $32.03 | $48.35 | — |
| Low | $20.16 | $20.19 | $44.81 | — |
| High | $23.68 | $38.37 | $50.93 | — |
| Analysts (Rev / EPS) | 5 / 5 | 7 / 6 | 2 / 1 | 1 / — |